David Dodwell

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

R. Charles Coombes, Emma Hall, Lorna J. Gibson et al. · New England Journal of Medicine · 2004 · 1.8K citations · Full text

Pharmacy, Endocrinology, Oncology +13

Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

R. Charles Coombes, CF Snowdon, Robert Paridaens et al. · The Lancet · 2007 · 909 citations

Medicine, Endocrinology, Oncology +4

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials

Carolyn Taylor, Candace R. Correa, Frances Duane et al. · Journal of Clinical Oncology · 2017 · 786 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study

Brian Leyland‐Jones, Marek Pawlicki, Tadeusz Pieńkowski et al. · Journal of Clinical Oncology · 2005 · 665 citations · Full text

Medicine, Oncology, Pharmacology +15

Addressing overtreatment of screen detected DCIS; the LORIS trial

Adele Francis, Jeremy Thomas, Lesley Fallowfield et al. · European Journal of Cancer · 2015 · 375 citations · Full text

Medicine, Internal Medicine, Preventive Medicine +5